|
CHEMBL3837
|
P07711
|
Cathepsin L |
99.70%
|
96.61%
|
|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.68%
|
98.95%
|
|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
99.46%
|
97.25%
|
|
CHEMBL299
|
P17252
|
Protein kinase C alpha |
99.12%
|
98.03%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
98.51%
|
96.09%
|
|
CHEMBL2955
|
O95136
|
Sphingosine 1-phosphate receptor Edg-5 |
98.37%
|
92.86%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
98.36%
|
93.56%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
98.24%
|
98.94%
|
|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
97.67%
|
98.33%
|
|
CHEMBL3060
|
Q9Y345
|
Glycine transporter 2 |
97.65%
|
99.17%
|
|
CHEMBL5043
|
Q6P179
|
Endoplasmic reticulum aminopeptidase 2 |
97.23%
|
91.81%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
97.19%
|
92.38%
|
|
CHEMBL4026
|
P40763
|
Signal transducer and activator of transcription 3 |
97.16%
|
82.69%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
96.93%
|
97.09%
|
|
CHEMBL220
|
P22303
|
Acetylcholinesterase |
96.89%
|
94.45%
|
|
CHEMBL2815
|
P04629
|
Nerve growth factor receptor Trk-A |
96.72%
|
87.16%
|
|
CHEMBL3892
|
Q99500
|
Sphingosine 1-phosphate receptor Edg-3 |
96.41%
|
97.29%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
95.99%
|
96.47%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
95.81%
|
100.00%
|
|
CHEMBL1907594
|
P30926
|
Neuronal acetylcholine receptor; alpha3/beta4 |
95.21%
|
97.23%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
95.17%
|
96.85%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
94.46%
|
97.50%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
94.45%
|
100.00%
|
|
CHEMBL4123
|
P30989
|
Neurotensin receptor 1 |
93.95%
|
96.67%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
93.87%
|
94.66%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
93.84%
|
95.71%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
93.81%
|
97.14%
|
|
CHEMBL221
|
P23219
|
Cyclooxygenase-1 |
93.71%
|
90.17%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
93.35%
|
100.00%
|
|
CHEMBL3776
|
Q14790
|
Caspase-8 |
93.21%
|
97.06%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
93.11%
|
91.19%
|
|
CHEMBL3437
|
Q16853
|
Amine oxidase, copper containing |
92.71%
|
94.00%
|
|
CHEMBL283
|
P08254
|
Matrix metalloproteinase 3 |
92.31%
|
97.29%
|
|
CHEMBL4072
|
P07858
|
Cathepsin B |
92.24%
|
93.67%
|
|
CHEMBL2996
|
Q05655
|
Protein kinase C delta |
92.16%
|
97.79%
|
|
CHEMBL3976
|
Q9UHL4
|
Dipeptidyl peptidase II |
92.11%
|
92.29%
|
|
CHEMBL230
|
P35354
|
Cyclooxygenase-2 |
92.01%
|
89.63%
|
|
CHEMBL2274
|
Q9H228
|
Sphingosine 1-phosphate receptor Edg-8 |
91.93%
|
100.00%
|
|
CHEMBL237
|
P41145
|
Kappa opioid receptor |
91.81%
|
98.10%
|
|
CHEMBL3176
|
O43603
|
Galanin receptor 2 |
91.71%
|
98.89%
|
|
CHEMBL259
|
P32245
|
Melanocortin receptor 4 |
91.64%
|
95.38%
|
|
CHEMBL4793
|
Q86TI2
|
Dipeptidyl peptidase IX |
91.43%
|
96.95%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
91.22%
|
90.71%
|
|
CHEMBL5163
|
Q9NY46
|
Sodium channel protein type III alpha subunit |
91.19%
|
96.90%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
90.80%
|
93.00%
|
|
CHEMBL5103
|
Q969S8
|
Histone deacetylase 10 |
90.79%
|
90.08%
|
|
CHEMBL236
|
P41143
|
Delta opioid receptor |
90.54%
|
99.35%
|
|
CHEMBL2492
|
P36544
|
Neuronal acetylcholine receptor protein alpha-7 subunit |
90.37%
|
88.42%
|
|
CHEMBL3238
|
P23786
|
Carnitine palmitoyltransferase 2 |
88.88%
|
94.05%
|
|
CHEMBL2107
|
P61073
|
C-X-C chemokine receptor type 4 |
88.61%
|
93.10%
|
|
CHEMBL3018
|
Q9Y5Y6
|
Matriptase |
88.18%
|
98.33%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
88.09%
|
97.64%
|
|
CHEMBL3392948
|
Q9NP59
|
Solute carrier family 40 member 1 |
87.93%
|
95.00%
|
|
CHEMBL4769
|
O95749
|
Geranylgeranyl pyrophosphate synthetase |
87.63%
|
92.08%
|
|
CHEMBL2094135
|
Q96BI3
|
Gamma-secretase |
87.02%
|
98.05%
|
|
CHEMBL4657
|
Q6V1X1
|
Dipeptidyl peptidase VIII |
86.92%
|
97.21%
|
|
CHEMBL4777
|
P25929
|
Neuropeptide Y receptor type 1 |
86.79%
|
96.67%
|
|
CHEMBL5979
|
P05186
|
Alkaline phosphatase, tissue-nonspecific isozyme |
86.24%
|
85.40%
|
|
CHEMBL1744525
|
P43490
|
Nicotinamide phosphoribosyltransferase |
86.02%
|
96.25%
|
|
CHEMBL2007625
|
O75874
|
Isocitrate dehydrogenase [NADP] cytoplasmic |
85.93%
|
99.00%
|
|
CHEMBL206
|
P03372
|
Estrogen receptor alpha |
85.47%
|
97.64%
|
|
CHEMBL1907605
|
P24864
|
Cyclin-dependent kinase 2/cyclin E1 |
84.89%
|
92.88%
|
|
CHEMBL4005
|
P42336
|
PI3-kinase p110-alpha subunit |
84.32%
|
97.47%
|
|
CHEMBL3024
|
P53350
|
Serine/threonine-protein kinase PLK1 |
84.07%
|
97.43%
|
|
CHEMBL3430907
|
Q96GD4
|
Aurora kinase B/Inner centromere protein |
83.76%
|
97.50%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
83.13%
|
94.33%
|
|
CHEMBL335
|
P18031
|
Protein-tyrosine phosphatase 1B |
82.65%
|
95.17%
|
|
CHEMBL4816
|
Q9Y243
|
Serine/threonine-protein kinase AKT3 |
82.28%
|
96.28%
|
|
CHEMBL2073
|
P07947
|
Tyrosine-protein kinase YES |
82.27%
|
83.14%
|
|
CHEMBL4625
|
Q07817
|
Apoptosis regulator Bcl-X |
82.02%
|
99.77%
|
|
CHEMBL4394
|
Q9NYA1
|
Sphingosine kinase 1 |
81.96%
|
96.03%
|
|
CHEMBL1075094
|
Q16236
|
Nuclear factor erythroid 2-related factor 2 |
81.89%
|
96.00%
|
|
CHEMBL255
|
P29275
|
Adenosine A2b receptor |
81.63%
|
98.59%
|
|
CHEMBL2413
|
P32246
|
C-C chemokine receptor type 1 |
81.35%
|
89.50%
|
|
CHEMBL5619
|
P27695
|
DNA-(apurinic or apyrimidinic site) lyase |
81.19%
|
91.11%
|
|
CHEMBL5255
|
O00206
|
Toll-like receptor 4 |
81.17%
|
92.50%
|
|
CHEMBL3145
|
P42338
|
PI3-kinase p110-beta subunit |
81.12%
|
98.75%
|
|
CHEMBL238
|
Q01959
|
Dopamine transporter |
81.10%
|
95.88%
|
|
CHEMBL5028
|
O14672
|
ADAM10 |
80.95%
|
97.50%
|
|
CHEMBL4187
|
Q99250
|
Sodium channel protein type II alpha subunit |
80.88%
|
95.50%
|
|
CHEMBL4330
|
Q9NS75
|
Cysteinyl leukotriene receptor 2 |
80.72%
|
98.00%
|
|
CHEMBL3891
|
P07384
|
Calpain 1 |
80.59%
|
93.04%
|
|
CHEMBL268
|
P43235
|
Cathepsin K |
80.21%
|
96.85%
|
|
CHEMBL1907603
|
Q05586
|
Glutamate NMDA receptor; GRIN1/GRIN2B |
80.14%
|
95.89%
|